Ana Lameirinhas

9PUBLICATIONS
26CO-AUTHORS
Molecular targetsMedical virologyPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 25, 2023
High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer.

Sandra Torres-Ruiz, Eduardo Tormo, Iris Garrido-Cano

|Nov 11, 2022
Role of SALL4 in HER2+ Breast Cancer Progression: Regulating PI3K/AKT Pathway.

Birlipta Pattanayak, Ana Lameirinhas, Sandra Torres-Ruiz

|Jul 02, 2021
Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer.

Anna Adam-Artigues, Iris Garrido-Cano, Juan Antonio Carbonell-Asins

|Dec 15, 2020
JmjC-KDMs KDM3A and KDM6B modulate radioresistance under hypoxic conditions in esophageal squamous cell carcinoma.

Catarina Macedo-Silva, Vera Miranda-Gonçalves, Ana Lameirinhas

|Dec 05, 2020
Clinical Significance of ARID1A and ANXA1 in HER-2 Positive Breast Cancer.

Rita Silva-Oliveira, Filipa Ferreira Pereira, Sara Petronilho

|Oct 14, 2020
Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer.

Iris Garrido-Cano, Vera Constâncio, Anna Adam-Artigues

Pageof 2

Frequent Collaborators

7 joint publications

Carmen Jerónimo

4 joint publications

Rui Henrique

3 joint publications

Pilar Eroles

2 joint publications

María Teresa Martínez